Cytokinetics | CYTK - Net Income



Cytokinetics reported $-134370000 in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Acadia Pharmaceuticals USD 26.67M 7.68M Jun/2025
Amgen USD 1.43B 298M Jun/2025
Bayer EUR -199000000 1.5B Jun/2025
Biogen USD 634.8M 394.3M Jun/2025
Bristol-Myers Squibb USD 1.31B 1.15B Jun/2025
Cytokinetics USD -134370000 27.01M Jun/2025
Eisai JPY 14.47B 13.52B Jun/2025
Eli Lilly USD 5.66B 2.9B Jun/2025
Exelixis USD 230.42M 70.8M Jul/2025
Geron USD -16375000 3.46M Jun/2025
Halozyme Therapeutics USD 165.16M 47.06M Jun/2025
Ionis Pharmaceuticals USD 123.55M 270.49M Jun/2025
Ligand Pharmaceuticals USD 4.85M 47.3M Jun/2025
Merck USD 4.43B 652M Jun/2025
Novartis USD 4.02B 418M Jun/2025
Pfizer USD 2.91B 58M Jun/2025
Regeneron Pharmaceuticals USD 1.39B 582.9M Jun/2025
Roche Holding CHF 1.01B 2.12B Dec/2024
Sanofi EUR 3.94B 2.07B Jun/2025